Samath Jamie - Dec 10, 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
CFO and Head of Business Techn
Signature
By: Thanh Nhan Phan For: Samath, Jamie
Stock symbol
ISRG
Transactions as of
Dec 10, 2024
Transactions value $
-$73,744
Form type
4
Date filed
12/11/2024, 12:50 PM
Previous filing
Dec 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $41.1K +135 +1.54% $304.67 8.89K Dec 10, 2024 Direct F1
transaction ISRG Common Stock Sale -$72.9K -135 -1.52% $540.16 8.76K Dec 10, 2024 Direct F1
transaction ISRG Common Stock Options Exercise $31K +135 +1.54% $229.39 8.89K Dec 10, 2024 Direct F1
transaction ISRG Common Stock Sale -$72.9K -135 -1.52% $540.16 8.76K Dec 10, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -135 -3.71% $0.00 3.5K Dec 10, 2024 Common Stock 135 $229.39 Direct F1, F2
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -135 -3.71% $0.00 3.5K Dec 10, 2024 Common Stock 135 $304.67 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.
F2 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
F3 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.